In a significant move, the U.S. Food and Drug Administration has provided De Novo authorisation Clairity Breast, the novel, ...

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...